Literature DB >> 19816238

Pre-S2 deletions of hepatitis B virus and hepatocellular carcinoma in children.

Hsiang-Po Huang1, Hong-Yuan Hsu, Chi-Ling Chen, Yen-Hsuan Ni, Hurng-Yi Wang, Daw-Jen Tsuei, Cheng-Lun Chiang, Yi-Chen Tsai, Huey-Ling Chen, Mei-Hwei Chang.   

Abstract

UNLABELLED: The cause of early oncogenesis in hepatitis B virus (HBV)-related childhood hepatocellular carcinoma (HCC) remains unclear. This study investigated whether pre-S deletion of HBV is related to childhood HCC. By using nested polymerase chain reaction, we compared the pre-S sequence of HBV from sera of children with HCC against control children with similar chronic HBV infection. The HBV in sera of children with HCC had a significantly higher rate of pre-S deletion than that of children with chronic HBV infection (p = 0.008). All except one of the pre-S deletions from the HCC group involved the pre-S2 region, whereas no pre-S2 deletion was found in the chronic HBV group (p = 0.003). There was a trend whereby genotype-C sera had a higher rate of pre-S2 deletion than genotype-B sera (p = 0.11). A multivariate logistic regression model revealed that pre-S deletion was an independent risk factor for HCC in children (odds ratio: 36.69, p = 0.015). In conclusion, pre-S2 deletion does not need to take decades to occur; its presence in nearly half of children with HCC, in contrast to its absence in children with chronic HBV infection, suggests a link between pre-S2 deletion and HCC development in children. ABBREVIATIONS: :

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 19816238     DOI: 10.1203/PDR.0b013e3181c1b0b7

Source DB:  PubMed          Journal:  Pediatr Res        ISSN: 0031-3998            Impact factor:   3.756


  17 in total

Review 1.  Overview of hepatitis B viral replication and genetic variability.

Authors:  Shuping Tong; Peter Revill
Journal:  J Hepatol       Date:  2016-04       Impact factor: 25.083

2.  Functional characterization of hepatitis B virus core promoter mutants revealed transcriptional interference among co-terminal viral mRNAs.

Authors:  Chaoyang Chen; Haodi Jia; Fei Zhang; Yanli Qin; Li Zong; Quan Yuan; Yongxiang Wang; Ningshao Xia; Jisu Li; Yumei Wen; Shuping Tong
Journal:  J Gen Virol       Date:  2016-08-23       Impact factor: 3.891

Review 3.  Factors predicting occurrence and prognosis of hepatitis-B-virus-related hepatocellular carcinoma.

Authors:  Yi-Fang Han; Jun Zhao; Li-Ye Ma; Jian-Hua Yin; Wen-Jun Chang; Hong-Wei Zhang; Guang-Wen Cao
Journal:  World J Gastroenterol       Date:  2011-10-14       Impact factor: 5.742

Review 4.  Clinical significance of hepatitis B surface antigen mutants.

Authors:  Nicola Coppola; Lorenzo Onorato; Carmine Minichini; Giovanni Di Caprio; Mario Starace; Caterina Sagnelli; Evangelista Sagnelli
Journal:  World J Hepatol       Date:  2015-11-28

5.  Novel approach to identifying the hepatitis B virus pre-S deletions associated with hepatocellular carcinoma.

Authors:  Zhi-Mei Zhao; Yan Jin; Yu Gan; Yu Zhu; Tao-Yang Chen; Jin-Bing Wang; Yan Sun; Zhi-Gang Cao; Geng-Sun Qian; Hong Tu
Journal:  World J Gastroenterol       Date:  2014-10-07       Impact factor: 5.742

6.  Hepatitis B virus pre-S2 start codon mutations in Indonesian liver disease patients.

Authors:  Andi Utama; Marlinang Diarta Siburian; Ismail Fanany; Mariana Destila Bayu Intan; Rama Dhenni; Tri Shinta Kurniasih; Syafruddin A R Lelosutan; Wenny Astuti Achwan; Nasrul Zubir; Benyamin Lukito; Irawan Yusuf; Laurentius Adrianus Lesmana; Ali Sulaiman
Journal:  World J Gastroenterol       Date:  2012-10-14       Impact factor: 5.742

Review 7.  Hepatitis B virus genetic variants: biological properties and clinical implications.

Authors:  Shuping Tong; Jisu Li; Jack R Wands; Yu-Mei Wen
Journal:  Emerg Microbes Infect       Date:  2013-03-13       Impact factor: 7.163

8.  Update on the Risk of Hepatocellular Carcinoma in Chronic Hepatitis B Virus Infection.

Authors:  Axel Hsu; Ching-Lung Lai; Man-Fung Yuen
Journal:  Curr Hepat Rep       Date:  2011-02-19

9.  A ubiquitin independent degradation pathway utilized by a hepatitis B virus envelope protein to limit antigen presentation.

Authors:  Yuanjie Liu; James S Testa; Ramila Philip; Timothy M Block; Anand S Mehta
Journal:  PLoS One       Date:  2011-09-28       Impact factor: 3.240

10.  Associations between pre-S deletion mutation of hepatitis B virus and risk of hepatocellular carcinoma in the Asian population: a meta-analysis.

Authors:  Chao Wang; Zhaowei Teng; Yun Zhu; Allan Z Zhao; Chunhua Sun
Journal:  Med Sci Monit       Date:  2015-04-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.